{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:27:34Z","timestamp":1762543654317},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,24]]},"DOI":"10.7759\/cureus.27213","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T03:46:13Z","timestamp":1658720773000},"source":"Crossref","is-referenced-by-count":4,"title":["New-Onset Ocular Myasthenia Gravis After Booster Dose of COVID-19 Vaccine"],"prefix":"10.7759","author":[{"given":"Ana","family":"Abicic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Sitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Adamec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ervina","family":"Bilic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Habek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.01.003","article-title":"Ocular myasthenia","volume":"36","author":"Al-Haidar M","year":"2018","unstructured":"Al-Haidar M, Benatar M, Kaminski HJ. Ocular myasthenia. Neurol Clin. 2018, 36:241-51. 10.1016\/j.ncl.2018.01.003","journal-title":"Neurol Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05776-0","article-title":"Miller Fisher syndrome following Pfizer COVID-19 vaccine","volume":"43","author":"Abi\u010di\u0107 A","year":"2022","unstructured":"Abi\u010di\u0107 A, Adamec I, Habek M. Miller Fisher syndrome following Pfizer COVID-19 vaccine. Neurol Sci. 2022, 43:1495-7. 10.1007\/s10072-021-05776-0","journal-title":"Neurol Sci"},{"key":"ref3","article-title":"Coincidental onset of ocular myasthenia following ChAdOx1 n-CoV-19 vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"24","author":"Galassi G","year":"2022","unstructured":"Galassi G, Rispoli V, Iori E, Ariatti A, Marchioni A. Coincidental onset of ocular myasthenia following ChAdOx1 n-CoV-19 vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Isr Med Assoc J. 2022, 24:9-10.","journal-title":"Isr Med Assoc J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e50","article-title":"Early-onset myasthenia gravis following COVID-19 vaccination","volume":"37","author":"Lee MA","year":"2022","unstructured":"Lee MA, Lee C, Park JH, Lee JH. Early-onset myasthenia gravis following COVID-19 vaccination. J Korean Med Sci. 2022, 37:e50. 10.3346\/jkms.2022.37.e50","journal-title":"J Korean Med Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/21501327211051933","article-title":"A case of COVID-19 vaccine associated new diagnosis myasthenia gravis","volume":"12","author":"Chavez A","year":"2021","unstructured":"Chavez A, Pougnier C. A case of COVID-19 vaccine associated new diagnosis myasthenia gravis. J Prim Care Community Health. 2021, 12:21501327211051933. 10.1177\/21501327211051933","journal-title":"J Prim Care Community Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020672","article-title":"Disorders of the cholinergic system in COVID-19 era\u2014a review of the latest research","volume":"23","author":"Kopa\u0144ska M","year":"2022","unstructured":"Kopa\u0144ska M, Batoryna M, Bartman P, Szczygielski J, Bana\u015b-Z\u0105bczyk A. Disorders of the cholinergic system in COVID-19 era\u2014a review of the latest research. Int J Mol Sci. 2022, 23:10.3390\/ijms23020672","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-244146","article-title":"Temporal association between SARS-CoV-2 and new-onset myasthenia gravis: is it causal or coincidental?","volume":"14","author":"Muralidhar Reddy Y","year":"2021","unstructured":"Muralidhar Reddy Y, B SK, Osman S, Murthy JM. Temporal association between SARS-CoV-2 and new-onset myasthenia gravis: is it causal or coincidental?. BMJ Case Rep. 2021, 14:10.1136\/bcr-2021-244146","journal-title":"BMJ Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01694-9","article-title":"Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial","volume":"398","author":"Liu X","year":"2021","unstructured":"Liu X, Shaw RH, Stuart AS, et al.. Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial. Lancet. 2021, 398:856-69. 10.1016\/S0140-6736(21)01694-9","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14802-7","article-title":"Vaccination and autoimmune disease: what is the evidence?","volume":"362","author":"Wraith DC","year":"2003","unstructured":"Wraith DC, Goldman M, Lambert PH. Vaccination and autoimmune disease: what is the evidence?. Lancet. 2003, 362:1659-66. 10.1016\/S0140-6736(03)14802-7","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination","volume":"9","author":"Watad A","year":"2021","unstructured":"Watad A, De Marco G, Mahajna H, et al.. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination. Vaccines (Basel). 2021, 9:10.3390\/vaccines9050435","journal-title":"Vaccines (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11140-9","article-title":"Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients","volume":"269","author":"Sansone G","year":"2022","unstructured":"Sansone G, Bonifati DM. Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients. J Neurol. 2022, 269:3965-81. 10.1007\/s00415-022-11140-9","journal-title":"J Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120225","article-title":"Flare of myasthenia gravis induced by COVID-19 vaccines","volume":"436","author":"Ishizuchi K","year":"2022","unstructured":"Ishizuchi K, Takizawa T, Sekiguchi K, Motegi H, Oyama M, Nakahara J, Suzuki S. Flare of myasthenia gravis induced by COVID-19 vaccines. J Neurol Sci. 2022, 436:120225. 10.1016\/j.jns.2022.120225","journal-title":"J Neurol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/105239-new-onset-ocular-myasthenia-gravis-after-booster-dose-of-covid-19-vaccine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:21Z","timestamp":1707507621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/105239-new-onset-ocular-myasthenia-gravis-after-booster-dose-of-covid-19-vaccine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,24]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.27213","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,24]]}}}